Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Novavax COVID-19 vaccine meets trial endpoints

February 11, 2022 Medical Communications

Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …
News

Sickest patients face record long waits for hospital bed

February 11, 2022 Medical Communications

According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …
News

Researchers find molecular treatment works against metastatic cancer spread to the brain

February 11, 2022 Medical Communications

According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting …
News

NICE recommends new combination for untreated advanced kidney cancer

February 4, 2022 Medical Communications

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final …
News

NICE issues FAD for Forxiga in adults with chronic kidney disease

February 4, 2022 Medical Communications

NICE has issued a Final Appraisal Document (FAD) recommending Forxiga (dapagliflozin) within its marketing authorisation for the treatment of adults …
News

Emmes supports new collaboration to advance COVID-19 research for children

February 4, 2022 Medical Communications

Clinical research organisation, Emmes, announced its role as a Data Coordinating Center on a team whose work has accelerated paediatric …
News

Measles jab rate in England falls to ten percent below recommended rate

February 1, 2022 Medical Communications

Over one in 10 school entry-age children in England are at risk of measles due to not receiving their vaccine …
News

RDIF, AstraZeneca and others invest in treatments for resistant arterial hypertension

February 1, 2022 Medical Communications

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca, and Unicorn Capital Partners, a biotech-specialised VC fund, announced …
News

Supplemental NDA accepted for leukaemia treatment in China

January 28, 2022 Medical Communications

BeiGene, focused on developing innovative and affordable medicines, announced that the Center for Drug Evaluation (CDE) of the China National …
News

India: DCGI approval for trialling of nasal COVID-19 vaccine

January 28, 2022 Medical Communications

The Drugs Controller General of India (DCGI) has given permission to Bharat Biotech to conduct clinical trials for the use …
News

The downfall of COVID-19 lies in new generation anti-viral drugs, says WHO

January 28, 2022 Medical Communications

In a BBC News interview, WHO shared their views against easing pandemic restrictions, as new variants flare up anywhere until …
News

EU health ministers consider fourth COVID-19 vaccine dose

January 21, 2022 Medical Communications

European Union health ministers will try to find a common line on Friday over a potential fourth dose of COVID-19 …
News

Amid plans to ease COVID restrictions, dialysis patients remain vulnerable to Omicron

January 21, 2022 Medical Communications

As the government in England relaxes COVID-19 restrictions, new data from the Francis Crick Institute raise concerns over the impact …
News

Artificial pancreas may prove life-changing for young children with diabetes

January 21, 2022 Medical Communications

Cambridge researchers have developed an artificial pancreas which may beat standard treatment in controlling Type 1 diabetes in young children. …
News

Clover reveals positive data from Phase II/III COVID-19 vaccine trial

January 21, 2022 Medical Communications

Clover Biopharmaceuticals has announced that final efficacy data from SPECTRA, a global Phase II/III clinical trial into its COVID-19 vaccine …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025